Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients.
第一作者:
Getnet,Yimer
第一单位:
Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);炔类(Alkynes);抗HIV药(Anti-HIV Agents);抗生素类, 抗结核(Antibiotics, Antitubercular);苯并恶嗪类(Benzoxazines);病例对照研究(Case-Control Studies);共病现象(Comorbidity);环丙烷类(Cyclopropanes);女(雌)性(Female);基因型(Genotype);HIV感染(HIV Infections);人类(Humans);肝(Liver);男(雄)性(Male);中年人(Middle Aged);遗传药理学(Pharmacogenetics);前瞻性研究(Prospective Studies);利福平(Rifampin);时间因素(Time Factors);结核(Tuberculosis)
DOI
10.1371/journal.pone.0027810
PMID
22162992
发布时间
2021-10-21
- 浏览50
PloS one
e27810页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



